Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media

Ron Dagan, Candice E. Johnson, Samuel Mclinn, Nazha Abughali, Jesus Feris, Eugene Leibovitz, Daniel J. Burch, Michael R. Jacobs

Research output: Contribution to journalArticlepeer-review

178 Scopus citations


Objectives. To compare the bacteriologic and clinical efficacy of amoxicillin/clavulanate and azithromycin in patients with acute otitis media (AOM), particularly the ability to eradicate the predominant AOM pathogens from middle ear fluid as assessed by mandatory second tympanocentesis. Methods. In this single blind study 238 infants and children with AOM were randomized to receive amoxicillin/clavulanate (45/6.4 mg/kg/day in two divided doses for 10 days) or azithromycin (10 mg/kg on Day 1, then 5 mg/kg daily on Days 2 through 5). Tympanocentesis was performed before the first dose and repeated on Day 4, 5 or 6. Clinical response was assessed at end of therapy between Days 12 and 14 and at follow-up between Days 22 and 28. Results. Amoxicillin/clavulanate was significantly more likely to eradicate all bacterial pathogens [83% (54 of 65) vs. 49% (35 of 71), P = 0.001] and Haemophilus influenzae [87% (26 of 30) vs. 39% (13 of 33), P = 0.0001] from middle ear fluid than was azithromycin. Amoxicillin/clavulanate was also more likely to eradicate Streptococcus pneumoniae, but the difference was not statistically significant [90% (18 of 20) vs. 68% (3 of 19), P = 0.095]. On Days 12 to 14, signs and symptoms were more likely to resolve completely or improve in all culture-positive patients [86% (60 of 70) vs. 70% (51 of 73), P = 0.023] and in those with H. influenzae infections [91% (30 of 33) vs. 65% (22 of 34), P = 0.010] who received amoxicillin/clavulanate compared with those who received azithromycin. Otherwise there were no significant differences between groups in clinical outcomes on Days 12 to 14 or at follow-up. Conclusions. Our findings indicate that amoxicillin/clavulanate has superior bacteriologic and clinical efficacy compared with azithromycin in children with AOM.

Original languageEnglish
Pages (from-to)95-104
Number of pages10
JournalPediatric Infectious Disease Journal
Issue number2
StatePublished - 1 Feb 2000
Externally publishedYes


  • Acute otitis media
  • Amoxicillin/clavulanate
  • Azithromycin
  • Bacteriologic care
  • Treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media'. Together they form a unique fingerprint.

Cite this